CN105521393A - Rhizoma Atractylodis Macrocephalae powder for treating ulcerative colitis - Google Patents

Rhizoma Atractylodis Macrocephalae powder for treating ulcerative colitis Download PDF

Info

Publication number
CN105521393A
CN105521393A CN201410508915.3A CN201410508915A CN105521393A CN 105521393 A CN105521393 A CN 105521393A CN 201410508915 A CN201410508915 A CN 201410508915A CN 105521393 A CN105521393 A CN 105521393A
Authority
CN
China
Prior art keywords
ulcerative colitis
rhizoma atractylodis
atractylodis macrocephalae
treating ulcerative
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410508915.3A
Other languages
Chinese (zh)
Inventor
张秋云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410508915.3A priority Critical patent/CN105521393A/en
Publication of CN105521393A publication Critical patent/CN105521393A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a Rhizoma Atractylodis Macrocephalae powder for treating ulcerative colitis, prepared with the following components: 10 g of Rhizoma Atractylodis Macrocephalae, 6 g of Cortex Fraxini, 5 g of Radix Aucklandiae, 5 g of Pericarpium Citri Reticulatae, 10 g of Folium Nelumbinis dried and 2 g of Fructus Amomi. The powder is effective in clearing heat, regulating qi, transferring heat, removing pus and checking diarrhea and is applicable to treating ulcerative colitis with qi stagnation and blood stasis syndrome.

Description

A kind of Rhizoma Atractylodis Macrocephalae being used for the treatment of ulcerative colitis falls apart
Technical field
The present invention relates to a kind of Rhizoma Atractylodis Macrocephalae being used for the treatment of ulcerative colitis to fall apart.
Background technology
Ulcerative colitis is a kind of agnogenic rectum postcolon inflammatory lesion, it is generally acknowledged with immunity, heredity, infect, Neuropsychical facto etc. is relevant, the morbidity of primary disease is basic with immunologic mechanism, and take inherited genetic factors as background, infection and Nervous and Mental Factors are inducements.
Ulcerative colitis disease just or outbreak time, affiliated damp-heat syndrome, to get rid of evils as urgency, for a long time sick or catabasis common weakness of the spleen and stomach or syndrome of yang deficiency of spleen and kidney, controlling with righting is elder generation.
Summary of the invention
The object of this invention is to provide a kind of Rhizoma Atractylodis Macrocephalae being used for the treatment of ulcerative colitis to fall apart.
A kind of Rhizoma Atractylodis Macrocephalae being used for the treatment of ulcerative colitis of the present invention falls apart and is prepared from by following component:
Rhizoma Atractylodis Macrocephalae 10g, Cortex Fraxini 6g, Radix Aucklandiae 5g, Pericarpium Citri Reticulatae 5g, dry Folium Nelumbinis 10g and Fructus Amomi 2g.
The present invention has effect of Qingre Liqi heat-transformation, suppuration antidiarrheal, is suitable for ulcerative colitis qi stagnation and blood stasis type.
Detailed description of the invention
Formula: Rhizoma Atractylodis Macrocephalae 10g, Cortex Fraxini 6g, Radix Aucklandiae 5g, Pericarpium Citri Reticulatae 5g, dry Folium Nelumbinis 10g and Fructus Amomi 2g.
Usage: take with boiled water, every day 2 doses, is used in conjunction 7 days.
The present invention has effect of Qingre Liqi heat-transformation, suppuration antidiarrheal, is suitable for ulcerative colitis qi stagnation and blood stasis type.

Claims (1)

1. the Rhizoma Atractylodis Macrocephalae being used for the treatment of ulcerative colitis falls apart, and it is characterized in that: Rhizoma Atractylodis Macrocephalae 10g, Cortex Fraxini 6g, Radix Aucklandiae 5g, Pericarpium Citri Reticulatae 5g, dry Folium Nelumbinis 10g and Fructus Amomi 2g.
CN201410508915.3A 2014-09-29 2014-09-29 Rhizoma Atractylodis Macrocephalae powder for treating ulcerative colitis Pending CN105521393A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410508915.3A CN105521393A (en) 2014-09-29 2014-09-29 Rhizoma Atractylodis Macrocephalae powder for treating ulcerative colitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410508915.3A CN105521393A (en) 2014-09-29 2014-09-29 Rhizoma Atractylodis Macrocephalae powder for treating ulcerative colitis

Publications (1)

Publication Number Publication Date
CN105521393A true CN105521393A (en) 2016-04-27

Family

ID=55764136

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410508915.3A Pending CN105521393A (en) 2014-09-29 2014-09-29 Rhizoma Atractylodis Macrocephalae powder for treating ulcerative colitis

Country Status (1)

Country Link
CN (1) CN105521393A (en)

Similar Documents

Publication Publication Date Title
CN105521393A (en) Rhizoma Atractylodis Macrocephalae powder for treating ulcerative colitis
CN105521108A (en) Modified radix aucklandiae and rhizoma coptidis pill for treating ulcerative colitis
CN105521396A (en) Ulcerative colitis treatment powder containing Pericarpium Citri Reticulatae and Folium Nelumbinis
CN105521111A (en) Compound Herba Portulacae decoction for treating ulcerative colitis
CN105521316A (en) Amaranthus mangostanus congee for treating ulcerative colitis
CN105521456A (en) Pill for treating ulcerative colitis
CN105521109A (en) Dampness-dispelling decoction for treating ulcerative colitis
CN105521348A (en) Stasis-removing decoction for treating ulcerative colitis
CN105521349A (en) Cortex Phellodendri decoction for treating ulcerative colitis
CN105434741A (en) Lotus leaf decoction for treatment of ulcerative colitis
CN105521028A (en) Modified Radix Aucklandiae Radix Astragali pill for treating ulcerative colitis
CN105521347A (en) Intestine-moistening qi-promoting decoction for treating ulcerative colitis
CN105521455A (en) Diarrhea relieving pill for treating ulcerative colitis
CN105521187A (en) Semen arecae pill for treating ulcerative colitis
CN105521459A (en) Bowel-benefiting pill for treating ulcerative colitis
CN105521185A (en) Fructus Corni application for treating ulcerative colitis
CN105434860A (en) Sophora flavescens formula for treatment of ulcerative colitis
CN105521395A (en) Spleen nourishing and stomach harmonizing decoction for treating ulcerative colitis
CN105521041A (en) Toxicity removing and heat clearing decoction for treating ulcerative colitis
CN105434592A (en) Rumex madaio Makino sophora flavescens decoction for treatment of ulcerative colitis
CN105521070A (en) Herba agrimoniae and radix platycodonis decoction for treating ulcerative colitis
CN105497369A (en) Pain dispelling decoction for treating ulcerative colitis
CN105434975A (en) Dahurian patrinia herb soup for treating ulcerative colitis
CN105521409A (en) Fructus Sophorae containing intestinal lavage decoction for treating ulcerative colitis
CN105434558A (en) Radix paeoniae alba cortex ailanthi decoction for treatment of ulcerative colitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160427

WD01 Invention patent application deemed withdrawn after publication